Skinvisible (SKVI) Interest Coverage Ratio (2010 - 2026)
Skinvisible's (SKVI) quarterly Interest Coverage Ratio came in at 0.79 in Q2 2026, up 17.19% year-over-year from 0.67 in Q2 2025, and up 11.34% quarter-over-quarter from 0.89 in Q1 2026.
Analysis
Skinvisible (SKVI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Interest Coverage Ratio across 17 years of filings, most recently posting 0.79 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio rose 17.19% year-over-year to 0.79; the TTM figure through Jun 2026 stood at 0.8 (up 17.07% YoY), while the FY2025 annual figure was 0.87, up 1.52% from the prior year.
- Interest Coverage Ratio came in at 0.79 for Q2 2026 at Skinvisible, up from 0.89 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.3 in Q2 2022 to a low of 1.18 in Q4 2024.
- Average Interest Coverage Ratio over 5 years is 0.65, with a median of 0.74 recorded in 2024.
- Year-over-year, Interest Coverage Ratio slumped 1536.24% in 2022 and soared 66.43% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 0.4 in 2022, then plunged by 101.93% to 0.82 in 2023, then plunged by 44.34% to 1.18 in 2024, then surged by 32.8% to 0.79 in 2025, then advanced by 0.17% to 0.79 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.79 in Q2 2026, 0.89 in Q1 2026, and 0.79 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 441.56 Bn | 434.99 Bn | 12.70 Bn | - |
| 3 | Merck | 364.45 Bn | 357.31 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.46 Bn | 259.77 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 158.77 Bn | 147.08 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - | -21.24 |
| 8 | Incyte | 25.31 Bn | 20.77 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn | 114.07 |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | -0.79 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.79 |
| Mar 31, 2026 | -0.89 |
| Dec 31, 2025 | -0.79 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | -0.95 |
| Mar 31, 2025 | -0.99 |
| Dec 31, 2024 | -1.18 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -0.86 |
| Mar 31, 2024 | -0.74 |
| Dec 31, 2023 | -0.82 |
| Sep 30, 2023 | -0.65 |
| Jun 30, 2023 | -0.67 |
| Mar 31, 2023 | -0.09 |
| Dec 31, 2022 | -0.40 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | -0.27 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | -0.03 |